E
Zai Lab Limited ZLAB
$14.07 -$0.15-1.06%
Recommendation
Sell
Prev Close
$13.72
Volume
465,965
Avg Vol (90D)
644,500
Market Cap
$1.35B
Dividend & Yield
--
52-Week Range
$13.67 - $39.50
P/E (TTM)
--
EPS (TTM)
-$34.61
My Lists My Alerts
Report
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Zai Lab files automatic ordinary shares offering
4/19/2024 - The Fly
Zai Lab (ZLAB, $14.22) Aroon Indicator entered a Downtrend on April 18, 2024.
4/19/2024 - Tickeron - Stocks
Zai Lab (ZLAB, $14.22) RSI Indicator left the oversold zone on April 18, 2024
4/19/2024 - Tickeron - Stocks
Zai Lab (ZLAB, $13.72) Aroon Indicator entered a Downtrend on April 17, 2024.
4/18/2024 - Tickeron - Stocks
Zai Lab (NASDAQ:ZLAB) Hits New 52-Week Low at $14.01
4/18/2024 - Ticker Report
Zai Lab (ZLAB, $14.42) Aroon Indicator entered a Downtrend on April 16, 2024.
4/17/2024 - Tickeron - Stocks
Zai Lab (NASDAQ:ZLAB) Shares Down 2.4%
4/17/2024 - Ticker Report
Genesis Investment Management LLP Sells 339,503 Shares of Zai Lab Limited (NASDAQ:ZLAB)
4/17/2024 - Ticker Report
A Risky Bet: Zai Lab's Uncertain Future
4/16/2024 - SeekingAlpha
Zai Lab (ZLAB, $14.2) Aroon Indicator entered a Downtrend on April 15, 2024.
4/16/2024 - Tickeron - Stocks
Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024
4/15/2024 - Business Wire
Zai Lab (NASDAQ:ZLAB) Reaches New 12-Month Low at $15.13
4/12/2024 - Ticker Report
Executive officers of Zai Lab 'do not anticipate selling any shares' in 2024
4/11/2024 - The Fly
Zai Lab Statement on Executive Management Teams Agreement on Share Activities
4/11/2024 - Business Wire
Zai Lab (NASDAQ:ZLAB) Shares Gap Up to $15.49
4/9/2024 - Ticker Report
Analysts' Opinions Are Mixed on These Healthcare Stocks: Inozyme Pharma (INZY), Zai Lab (ZLAB) and Idexx Laboratories (IDXX)
4/9/2024 - TipRanks Financial Blog
Zai Lab Limited (NASDAQ:ZLAB) CFO Sells $13,241.15 in Stock
4/8/2024 - Zolmax
Insider Selling: Zai Lab Limited (NASDAQ:ZLAB) Insider Sells $31,151.96 in Stock
4/8/2024 - Zolmax
China Universal Asset Management Co. Ltd. Boosts Position in Zai Lab Limited (NASDAQ:ZLAB)
4/6/2024 - Zolmax
Zai Lab Limited (NASDAQ:ZLAB) Insider Joshua L. Smiley Sells 1,988 Shares of Stock
4/6/2024 - Ticker Report
Zai Lab Limited (NASDAQ:ZLAB) CEO Sells $93,460.05 in Stock
4/6/2024 - Ticker Report
Zai Lab (NASDAQ:ZLAB) Reaches New 1-Year Low on Insider Selling
4/5/2024 - Zolmax
Frazor Titus Edmondson III Sells 885 Shares of Zai Lab Limited (NASDAQ:ZLAB) Stock
4/4/2024 - Zolmax
Zai Lab (NASDAQ:ZLAB) Sets New 12-Month Low at $15.53
4/3/2024 - Ticker Report
Zai Lab Presentations at AACR 2024 Annual Meeting to Showcase Ongoing Clinical Studies in Key Global Oncology Programs
4/2/2024 - Business Wire
Income Statement
Total Revenue (TTM)
$266.72M
EBITDA (TTM)
-$367.55M
EBIT (TTM)
-$376.57M
Net Income (TTM)
-$334.62M
Balance Sheet
Total Assets (Q)
$1.04B
Total Debt (Q)
$15.15M
Total Liabilities (Q)
$240.18M
Book Value Per Share (Q)
$81.89
Cash Flow
Cash from Operations (TTM)
-$198.18M
Cash from Investing (TTM)
-$10.78M
Cash from Financing (TTM)
-$6.43M
Net Change in Cash (TTM)
-$218.01M
Filings
Filing Date
Tuesday, February 27, 2024
Period Date
Sunday, December 31, 2023
Next Filing
Week of May 6 and 10 (est)
Price History
Loading...
Beta
0.55
7-Day Total Return
-3.12%
30-Day Total Return
-21.62%
60-Day Total Return
-32.55%
90-Day Total Return
-43.56%
Year to Date Total Return
-40.45%
1-Year Total Return
-59.49%
2-Year Total Return
-63.74%
3-Year Total Return
-90.56%
5-Year Total Return
-47.17%
52-week Low
Apr 17, 2024 - $13.67
52-week High
May 10, 2023 - $39.50
Valuation
Market Cap
$1.35B - Small Cap
Enterprise Value
$563.10M
Price/Sales (TTM)
0.50
Price/Book (Q)
0.17
Dividends and Shares
Shares Outstanding
9.70M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.zailaboratory.com
Phone Number
86 21 6163 2588
Address
Jinchuang Plaza
Building 1, Fourth Floor - 4560 Jinke Road
Pudong Shanghai, 201210
Country
China
Year Founded
2013
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally... more
NASDAQ 04/19/2024 4:00PM Eastern Quotes delayed
Weiss Ratings